These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 35365949)
1. Periplocymarin alleviates pathological cardiac hypertrophy via inhibiting the JAK2/STAT3 signalling pathway. Fan CL; Liang S; Ye MN; Cai WJ; Chen M; Hou YL; Guo J; Dai Y J Cell Mol Med; 2022 May; 26(9):2607-2619. PubMed ID: 35365949 [TBL] [Abstract][Full Text] [Related]
2. Protocatechuic aldehyde protects against isoproterenol-induced cardiac hypertrophy via inhibition of the JAK2/STAT3 signaling pathway. Fang X; Liu Y; Lu J; Hong H; Yuan J; Zhang Y; Wang P; Liu P; Ye J Naunyn Schmiedebergs Arch Pharmacol; 2018 Dec; 391(12):1373-1385. PubMed ID: 30132020 [TBL] [Abstract][Full Text] [Related]
3. The functional role of m6A demethylase ALKBH5 in cardiomyocyte hypertrophy. Meng C; Su H; Shu M; Shen F; Lu Y; Wu S; Su Z; Yu M; Yang D Cell Death Dis; 2024 Sep; 15(9):683. PubMed ID: 39294131 [TBL] [Abstract][Full Text] [Related]
4. Heat-shock transcription factor 1 is critically involved in the ischaemia-induced cardiac hypertrophy via JAK2/STAT3 pathway. Yuan L; Qiu L; Ye Y; Wu J; Wang S; Wang X; Zhou N; Zou Y J Cell Mol Med; 2018 Sep; 22(9):4292-4303. PubMed ID: 29992755 [TBL] [Abstract][Full Text] [Related]
5. Alleviation of Inflammation and Oxidative Stress in Pressure Overload-Induced Cardiac Remodeling and Heart Failure via IL-6/STAT3 Inhibition by Raloxifene. Huo S; Shi W; Ma H; Yan D; Luo P; Guo J; Li C; Lin J; Zhang C; Li S; Lv J; Lin L Oxid Med Cell Longev; 2021; 2021():6699054. PubMed ID: 33824698 [TBL] [Abstract][Full Text] [Related]
6. Leucine zipper protein 1 attenuates pressure overload-induced cardiac hypertrophy through inhibiting Stat3 signaling. Fan D; Jiang WL; Jin ZL; Cao JL; Li Y; He T; Zhang W; Peng L; Liu HX; Wu XY; Chen M; Fan YZ; He B; Yu WX; Wang HR; Hu XR; Lu ZB J Adv Res; 2024 Sep; 63():117-128. PubMed ID: 37806546 [TBL] [Abstract][Full Text] [Related]
7. Captopril attenuates TAC-induced heart failure via inhibiting Wnt3a/β-catenin and Jak2/Stat3 pathways. Zhang Y; Zhang L; Fan X; Yang W; Yu B; Kou J; Li F Biomed Pharmacother; 2019 May; 113():108780. PubMed ID: 30889487 [TBL] [Abstract][Full Text] [Related]
8. Chrysophanol attenuated isoproterenol-induced cardiac hypertrophy by inhibiting Janus kinase 2/signal transducer and activator of transcription 3 signaling pathway. Yuan J; Hong H; Zhang Y; Lu J; Yu Y; Bi X; Wang J; Ye J Cell Biol Int; 2019 Jun; 43(6):695-705. PubMed ID: 30977566 [TBL] [Abstract][Full Text] [Related]
9. FKBP12.6 protects heart from AngII-induced hypertrophy through inhibiting Ca Xiao YF; Zeng ZX; Guan XH; Wang LF; Wang CJ; Shi H; Shou W; Deng KY; Xin HB J Cell Mol Med; 2018 Jul; 22(7):3638-3651. PubMed ID: 29682889 [TBL] [Abstract][Full Text] [Related]
10. TWEAK/Fn14 mediates atrial-derived HL-1 myocytes hypertrophy via JAK2/STAT3 signalling pathway. Hao L; Ren M; Rong B; Xie F; Lin MJ; Zhao YC; Yue X; Han WQ; Zhong JQ J Cell Mol Med; 2018 Sep; 22(9):4344-4353. PubMed ID: 29971943 [TBL] [Abstract][Full Text] [Related]
11. FNDC5 attenuates obesity-induced cardiac hypertrophy by inactivating JAK2/STAT3-associated inflammation and oxidative stress. Geng Z; Fan WY; Zhou B; Ye C; Tong Y; Zhou YB; Xiong XQ J Transl Med; 2019 Apr; 17(1):107. PubMed ID: 30940158 [TBL] [Abstract][Full Text] [Related]
12. The oxoglutarate receptor 1 (OXGR1) modulates pressure overload-induced cardiac hypertrophy in mice. Omede A; Zi M; Prehar S; Maqsood A; Stafford N; Mamas M; Cartwright E; Oceandy D Biochem Biophys Res Commun; 2016 Oct; 479(4):708-714. PubMed ID: 27693579 [TBL] [Abstract][Full Text] [Related]
13. Opposing actions of extracellular signal-regulated kinase (ERK) and signal transducer and activator of transcription 3 (STAT3) in regulating microtubule stabilization during cardiac hypertrophy. Ng DC; Ng IH; Yeap YY; Badrian B; Tsoutsman T; McMullen JR; Semsarian C; Bogoyevitch MA J Biol Chem; 2011 Jan; 286(2):1576-87. PubMed ID: 21056972 [TBL] [Abstract][Full Text] [Related]
15. LncRNA AK045171 protects the heart from cardiac hypertrophy by regulating the SP1/MG53 signalling pathway. Xu L; Wang H; Jiang F; Sun H; Zhang D Aging (Albany NY); 2020 Feb; 12(4):3126-3139. PubMed ID: 32087602 [TBL] [Abstract][Full Text] [Related]
16. LKB1IP promotes pathological cardiac hypertrophy by targeting PTEN/Akt signalling pathway. Tian M; Jiang X; Li X; Yang J; Zhang C; Zhang W J Cell Mol Med; 2021 Mar; 25(5):2517-2529. PubMed ID: 33486894 [TBL] [Abstract][Full Text] [Related]
17. Gallic Acid Suppresses Cardiac Hypertrophic Remodeling and Heart Failure. Yan X; Zhang YL; Zhang L; Zou LX; Chen C; Liu Y; Xia YL; Li HH Mol Nutr Food Res; 2019 Mar; 63(5):e1800807. PubMed ID: 30521107 [TBL] [Abstract][Full Text] [Related]
18. SH2B1 is critical for the regulation of cardiac remodelling in response to pressure overload. Wu G; Liu Y; Huang H; Tang Y; Liu W; Mei Y; Wan N; Liu X; Huang C Cardiovasc Res; 2015 Jul; 107(2):203-15. PubMed ID: 26077624 [TBL] [Abstract][Full Text] [Related]
19. Exercise-induced peptide EIP-22 protect myocardial from ischaemia/reperfusion injury via activating JAK2/STAT3 signalling pathway. Zhang L; Wang X; Zhang H; Feng M; Ding J; Zhang B; Cheng Z; Qian L J Cell Mol Med; 2021 Apr; 25(7):3560-3572. PubMed ID: 33710777 [TBL] [Abstract][Full Text] [Related]
20. Role of nuclear unphosphorylated STAT3 in angiotensin II type 1 receptor-induced cardiac hypertrophy. Yue H; Li W; Desnoyer R; Karnik SS Cardiovasc Res; 2010 Jan; 85(1):90-9. PubMed ID: 19696070 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]